Literature search services are currently unavailable. During our hosting provider's UPS upgrade we experienced a hardware failure and are currently working to resolve the issue.

Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.

Germ-line mutations of the von Hippel-Lindau tumor suppressor gene (VHL) predispose individuals to a variety of human tumors, and somatic mutations of this gene have been identified in sporadic renal cell carcinomas and cerebellar hemangioblastomas. Two transcriptional elongation factors, Elongin B and C, were shown to bind in vitro and in vivo to a short, colinear region of the VHL protein (pVHL) that is frequently mutated in human tumors. A peptide replica of this region inhibited binding of pVHL to Elongin B and C whereas a point-mutant derivative, corresponding to a naturally occurring VHL missense mutation, had no effect. These results suggest that the tumor suppression function of pVHL may be linked to its ability to bind to Elongin B and C.

Pubmed ID: 7660130


  • Kibel A
  • Iliopoulos O
  • DeCaprio JA
  • Kaelin WG


Science (New York, N.Y.)

Publication Data

September 8, 1995

Associated Grants


Mesh Terms

  • Amino Acid Sequence
  • Animals
  • Carcinoma, Renal Cell
  • Genes, Tumor Suppressor
  • Germ-Line Mutation
  • Humans
  • Ligases
  • Mice
  • Molecular Sequence Data
  • Nuclear Proteins
  • Point Mutation
  • Recombinant Fusion Proteins
  • Transcription Factors
  • Transfection
  • Tumor Cells, Cultured
  • Tumor Suppressor Proteins
  • Ubiquitin-Protein Ligases
  • Von Hippel-Lindau Tumor Suppressor Protein
  • von Hippel-Lindau Disease